468 related articles for article (PubMed ID: 35215499)
1. Lipid Metabolism and Epigenetics Crosstalk in Prostate Cancer.
Pardo JC; Ruiz de Porras V; Gil J; Font A; Puig-Domingo M; Jordà M
Nutrients; 2022 Feb; 14(4):. PubMed ID: 35215499
[TBL] [Abstract][Full Text] [Related]
2. Epigenetics in prostate cancer: biologic and clinical relevance.
Jerónimo C; Bastian PJ; Bjartell A; Carbone GM; Catto JW; Clark SJ; Henrique R; Nelson WG; Shariat SF
Eur Urol; 2011 Oct; 60(4):753-66. PubMed ID: 21719191
[TBL] [Abstract][Full Text] [Related]
3. Crosstalk between metabolic reprogramming and epigenetics in cancer: updates on mechanisms and therapeutic opportunities.
Ge T; Gu X; Jia R; Ge S; Chai P; Zhuang A; Fan X
Cancer Commun (Lond); 2022 Nov; 42(11):1049-1082. PubMed ID: 36266736
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic Modifications and Modulators in Prostate Cancer.
Cimadamore A; Gasparrini S; Scarpelli M; Doria A; Mazzucchelli R; Massari F; Cheng L; Lopez-Beltran A; Montironi R
Crit Rev Oncog; 2017; 22(5-6):439-450. PubMed ID: 29604923
[TBL] [Abstract][Full Text] [Related]
5. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
Dobosy JR; Roberts JL; Fu VX; Jarrard DF
J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
[TBL] [Abstract][Full Text] [Related]
6. The epigenetics of prostate cancer diagnosis and prognosis: update on clinical applications.
Blute ML; Damaschke NA; Jarrard DF
Curr Opin Urol; 2015 Jan; 25(1):83-8. PubMed ID: 25405932
[TBL] [Abstract][Full Text] [Related]
7. Metabolic reprogramming as an emerging mechanism of resistance to endocrine therapies in prostate cancer.
Chetta P; Zadra G
Cancer Drug Resist; 2021; 4(1):143-162. PubMed ID: 35582011
[TBL] [Abstract][Full Text] [Related]
8. Metabolic recoding of epigenetics in cancer.
Wang YP; Lei QY
Cancer Commun (Lond); 2018 May; 38(1):25. PubMed ID: 29784032
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic reprogramming during prostate cancer progression: A perspective from development.
Goel S; Bhatia V; Biswas T; Ateeq B
Semin Cancer Biol; 2022 Aug; 83():136-151. PubMed ID: 33545340
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic mechanisms underlying prostate cancer radioresistance.
Macedo-Silva C; Benedetti R; Ciardiello F; Cappabianca S; Jerónimo C; Altucci L
Clin Epigenetics; 2021 Jun; 13(1):125. PubMed ID: 34103085
[TBL] [Abstract][Full Text] [Related]
11. Prostate Cancer Epigenetics: From Basic Mechanisms to Clinical Implications.
Yegnasubramanian S; De Marzo AM; Nelson WG
Cold Spring Harb Perspect Med; 2019 Apr; 9(4):. PubMed ID: 29959132
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer epigenetics and its clinical implications.
Yegnasubramanian S
Asian J Androl; 2016; 18(4):549-58. PubMed ID: 27212125
[TBL] [Abstract][Full Text] [Related]
13. Epigenetics-based diagnostic and therapeutic strategies: shifting the paradigm in prostate cancer.
Clermont PL
Epigenomics; 2023 Jan; 15(2):75-87. PubMed ID: 36974615
[TBL] [Abstract][Full Text] [Related]
14. Metabolomic profiling for the identification of novel diagnostic markers and therapeutic targets in prostate cancer: an update.
Lucarelli G; Loizzo D; Ferro M; Rutigliano M; Vartolomei MD; Cantiello F; Buonerba C; Di Lorenzo G; Terracciano D; De Cobelli O; Bettocchi C; Ditonno P; Battaglia M
Expert Rev Mol Diagn; 2019 May; 19(5):377-387. PubMed ID: 30957583
[TBL] [Abstract][Full Text] [Related]
15. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
16. Interplay Among Metabolism, Epigenetic Modifications, and Gene Expression in Cancer.
Huo M; Zhang J; Huang W; Wang Y
Front Cell Dev Biol; 2021; 9():793428. PubMed ID: 35004688
[TBL] [Abstract][Full Text] [Related]
17. Nutriepigenomics and malnutrition.
de Luca A; Hankard R; Borys JM; Sinnett D; Marcil V; Levy E
Epigenomics; 2017 Jun; 9(6):893-917. PubMed ID: 28571478
[TBL] [Abstract][Full Text] [Related]
18. Epigenetics in breast and prostate cancer.
Wu Y; Sarkissyan M; Vadgama JV
Methods Mol Biol; 2015; 1238():425-66. PubMed ID: 25421674
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic regulation of prostate cancer: the theories and the clinical implications.
Liao Y; Xu K
Asian J Androl; 2019; 21(3):279-290. PubMed ID: 30084432
[TBL] [Abstract][Full Text] [Related]
20. Epigenomic alterations in localized and advanced prostate cancer.
Lin PC; Giannopoulou EG; Park K; Mosquera JM; Sboner A; Tewari AK; Garraway LA; Beltran H; Rubin MA; Elemento O
Neoplasia; 2013 Apr; 15(4):373-83. PubMed ID: 23555183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
